Drug intelligence / Profile preview

racecadotril

Development stage
Phase 4
Lead developer
Bioprojet
Modality
Small Molecules
Administration
Oral
01

Overview

Racecadotril is an antidiarrheal medication that acts as a peripheral enkephalinase inhibitor. It is a prodrug that, after oral administration, is rapidly converted to its active metabolite thiorphan. Thiorphan inhibits the enzyme enkephalinase (also known as neutral endopeptidase) in the intestinal epithelium, protecting endogenous enkephalins from degradation. Enkephalins activate δ opioid receptor on enterocytes, leading to reduced cyclic adenosine monophosphate (cAMP) synthesis and decreased secretion of water and electrolytes into the gastrointestinal lumen. This mechanism reduces diarrhea-related hypersecretion without affecting intestinal motility or transit time, distinguishing it from μ-opioid receptor agonists like loperamide. Racecadotril does not cross the blood–brain barrier at therapeutic doses and has no effect on basal secretion or gastrointestinal transit[1][2][3][5][6].

Brand names
HidrasecTiorfanAcetorphan
Other names
acetorphan
02

Targets

DOR (Opioid Receptor Delta 1)NEP (Neutral Endopeptidase)

Beyond the preview

Go deeper on racecadotril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on racecadotril.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call